Dr Shadi Farhangrazi, CEO and Co-Founder of SMDG is an invited speaker at Bionow's BioFocus meeting speaking about SMDG's ground breaking technology platform: Medicines of Tomorrow. 

Professor Moein Moghimi, Co-Founder of SMDG and Professor of Pharmaceutics and Nanomedicine, Newcastle University, Invited speaker: Mechanisms responsible for initiation of adverse injection reactions to nanomedicines.  

Professor Moein Moghimi, Co-Founder of SMDG and Professor of Pharmaceutics and Nanomedicine, Newcastle University, Invited panelist: Overcoming RNA delivery challenges.  

Professor Moein Moghimi is an invited speaker: COVID vaccines and allergic reactions: facts and myths. 

Basel, Switzerland.
 

Professor Moein Moghimi, Co-Founder of SMDG is an invited Keynote Speaker: Brothers in arms: nanomedicine and the innate immunity. 

Professor Moein Moghimi, Co-Founder of SMDG and Professor of Pharmaceutics and Nanomedicine at Newcastle University is an invited keynote Soeaker: Advances in nucleic acid medicine delivery to the brain. 

Professor Moein Moghimi, Co-Founder of SMDG and Professor of Pharmaceutics and Nanomedicine at Newcastle University gives an Invited Lecture: "Self-assembled phage mimetics for crossing the blood-brain barrier: safe and efficient siRNA delivery to neurons and microglial cells."